Search results for “CCR9” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 326 patents, we discovered top 27 key players by total patent application. ChemoCentryx, Inc., Novartis AG, Millennium Pharmaceuticals, Inc. are dominant in this area. They take 65.95% of the total patent filing.
ChemoCentryx, Inc.
California, United States
Patent: 137
Novartis AG
Basel-Stadt, Switzerland
Patent: 54
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 24
Nogra Pharma Ltd.
DUBLIN, Ireland
Patent: 14
Encysive Pharmaceuticals, Inc.
Texas, United States
Patent: 12
TLA Targeted Immunotherapies AB
Sweden
Patent: 12
Norgine BV
Noord-Holland, Netherlands
Patent: 9
Ith Immune Therapy Holdings AB
Sweden
Patent: 9
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 5
Medinnova AS
Norway
Patent: 5
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 52 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing ChemoCentryx, Inc., MedImmune Ltd., Massachusetts Institute of Technology take 73.08% of patent filing during this period.
ChemoCentryx, Inc.
California, United States
Patent: 32
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 3
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 3
Avalon GloboCare Corp.
New Jersey, United States
Patent: 3
Keio University
Tokyo-to, Japan
Patent: 1
Celgene Corp.
New Jersey, United States
Patent: 1
Peking University Shenzhen Hospital
China
Patent: 1
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
Guangzhou Cellgenes Biotechnology Co.,Ltd
China
Patent: 1
Fudan University
Shanghai Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 52 patents in last 5 years, we discover 12 new entrants. MedImmune Ltd., Massachusetts Institute of Technology, Avalon GloboCare Corp. are the most active new entrants in this area.
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 3
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 3
Avalon GloboCare Corp.
New Jersey, United States
Patent: 3
Guangzhou Cellgenes Biotechnology Co.,Ltd
China
Patent: 1
Keio University
Tokyo-to, Japan
Patent: 1
Celgene Corp.
New Jersey, United States
Patent: 1
Fudan University
Shanghai Shi, China
Patent: 1
The Sixth Affiliated Hospital of Sun Yat-Sen University
China
Patent: 1
Peking University Shenzhen Hospital
China
Patent: 1
Shenzhen Aisheng Regenerative Medicine Technology Co., Ltd.
Guangdong Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 26 patents, we discovered top 7 universities and scientific research institutions by total patent application. Consejo Superior de Investigaciones Científicas, Massachusetts Institute of Technology, Kyoto University are dominant in this area. They take 50.00% of the total patent filing.
Consejo Superior de Investigaciones Científicas
Madrid, Spain
Patent: 5
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 3
Kyoto University
Kyoto-fu, Japan
Patent: 2
Morehouse School of Medicine
Georgia, United States
Patent: 2
Jilin University
Jilin Sheng, China
Patent: 1
Keio University
Tokyo-to, Japan
Patent: 1
Fudan University
Shanghai Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: